Nephros, Inc. (NEPH)

USD 1.48

(-3.9%)

Total Debt Summary of Nephros, Inc.

  • Nephros, Inc.'s latest annual total debt in 2023 was 1.83 Million USD , up 67.98% from previous year.
  • Nephros, Inc.'s latest quarterly total debt in 2024 Q2 was 1.58 Million USD , down -7.55% from previous quarter.
  • Nephros, Inc. reported annual total debt of 1.09 Million USD in 2022, down -2.67% from previous year.
  • Nephros, Inc. reported annual total debt of 1.12 Million USD in 2021, down -48.32% from previous year.
  • Nephros, Inc. reported quarterly total debt of 1.7 Million USD for 2024 Q1, down -6.92% from previous quarter.
  • Nephros, Inc. reported quarterly total debt of 780 Thousand USD for 2023 Q3, down -8.98% from previous quarter.

Annual Total Debt Chart of Nephros, Inc. (2023 - 2002)

Historical Annual Total Debt of Nephros, Inc. (2023 - 2002)

Year Total Debt Total Debt Growth
2023 1.83 Million USD 67.98%
2022 1.09 Million USD -2.67%
2021 1.12 Million USD -48.32%
2020 2.17 Million USD -14.62%
2019 2.54 Million USD 25.43%
2018 2.02 Million USD 21.86%
2017 1.66 Million USD 98.69%
2016 838 Thousand USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 1.35 Million USD 0.0%
2012 - USD 0.0%
2011 - USD -100.0%
2010 500 Thousand USD 0.0%
2009 - USD 0.0%
2008 - USD -100.0%
2007 781 Thousand USD -86.46%
2006 5.76 Million USD 534.22%
2005 909.56 Thousand USD 0.0%
2004 - USD -100.0%
2003 250 Thousand USD -59.02%
2002 610 Thousand USD 0.0%

Peer Total Debt Comparison of Nephros, Inc.

Name Total Debt Total Debt Difference
Akoya Biosciences, Inc. 85.7 Million USD 97.858%
AngioDynamics, Inc. 5.91 Million USD 68.955%
AtriCure, Inc. 74.49 Million USD 97.535%
Avinger, Inc. 15.39 Million USD 88.074%
Azenta, Inc. 60.43 Million USD 96.962%
BioLife Solutions, Inc. 42.69 Million USD 95.699%
The Cooper Companies, Inc. 2.56 Billion USD 99.929%
Daxor Corporation 755.65 Thousand USD -142.967%
Ekso Bionics Holdings, Inc. 7.16 Million USD 74.386%
Femasys Inc. 6.7 Million USD 72.601%
GlucoTrack, Inc. 196 Thousand USD -836.735%
Harvard Bioscience, Inc. 42.77 Million USD 95.708%
Hologic, Inc. 2.53 Billion USD 99.928%
ICU Medical, Inc. 1.7 Billion USD 99.892%
Intuitive Surgical, Inc. 89.8 Million USD 97.955%
KORU Medical Systems, Inc. 4.44 Million USD 58.696%
LeMaitre Vascular, Inc. 19.09 Million USD 90.385%
Innovative Eyewear, Inc. - USD -Infinity%
Innovative Eyewear, Inc. - USD -Infinity%
Masimo Corporation 970 Million USD 99.811%
Microbot Medical Inc. 231 Thousand USD -694.805%
Meihua International Medical Technologies Co., Ltd. 7.33 Million USD 74.956%
Merit Medical Systems, Inc. 891.35 Million USD 99.794%
NovoCure Limited 596.24 Million USD 99.692%
NEXGEL, Inc. 2.79 Million USD 34.382%
NEXGEL, Inc. 2.79 Million USD 34.382%
Singular Genomics Systems, Inc. 75.28 Million USD 97.561%
OraSure Technologies, Inc. 13.5 Million USD 86.404%
Pro-Dex, Inc. 13.54 Million USD 86.447%
Pulse Biosciences, Inc. 9.14 Million USD 79.921%
Predictive Oncology Inc. 2.85 Million USD 35.733%
Precision Optics Corporation, Inc. 3.43 Million USD 46.542%
QuidelOrtho Corporation 2.61 Billion USD 99.93%
Repligen Corporation 711.8 Million USD 99.742%
Sanara MedTech Inc. 11.79 Million USD 84.43%
STAAR Surgical Company 35.83 Million USD 94.876%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 342 Thousand USD -436.842%
DENTSPLY SIRONA Inc. 2.29 Billion USD 99.92%
Jin Medical International Ltd. 4.11 Million USD 55.361%